Oct 12, 2026, 8:05 AM
Sitara Peroxide reports annual profit of Rs 147.46 million for FY2026
Financial ResultThe board-approved results for the year ended June 30, 2026 show profit after tax of Rs 147.46 million and EPS of Rs 2.68, compared with a loss after tax of Rs 222.52 million and loss per share of Rs 4.04 in FY2025. Finance cost increased to Rs 38.73 million from Rs 4.74 million. No interim cash dividend, bonus shares, or rights shares were recommended. The company also announced an AGM for October 28, 2026 and share-transfer book closure from October 22 to October 28, 2026.
Key Findings
- Profit after tax was Rs 147,459,259, compared with a loss of Rs 222,518,844 in FY2025.
- EPS was Rs 2.68, versus a loss per share of Rs 4.04 in FY2025.
- Finance cost increased to Rs 38,725,966 from Rs 4,735,314.
- Balance-sheet cash and bank balances were Rs 3,877,179, compared with Rs 5,661,397 at June 30, 2025.
- No interim cash dividend, bonus shares, or rights shares were recommended; the AGM is scheduled for October 28, 2026.
Financial Performance
| Metric | PreviousYear ended June 30, 2025 | CurrentYear ended June 30, 2026 | Change |
|---|---|---|---|
| Profit / (loss) for the year | (222,518,844) | 147,459,259 | +166.3% |
| Earning per share - basic and diluted | (4.04) | 2.68 | +166.3% |
| Finance cost | 4,735,314 | 38,725,966 | +717.8% |
| Cash and bank balances | 5,661,397 | 3,877,179 | -31.5% |
| Current portion of long term financing | 101,739,606 | 12,000,000 | -88.2% |
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.